Delivery Order SPE2DB22D3004-SPE2DB24FPU71
Award Date 3/28/24
Potential Completion Date 3/29/24
Potential Value $29K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a $14,914.29 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of TREMFYA 100 MG/ML INJECTORML pharmaceutical products. This award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $29,153.94 firm fixed price delivery order for the pharmaceutical product TREMFYA 100 MG/ML INJECTORML. This order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to provide a comprehensive range of pharmaceutical products and medical supplies to support Department of Defense military...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of TREMFYA 100 MG/ML SYRINGEML. This $8,266.87 contract has an ultimate completion date of April 9, 2024. AmerisourceBergen Drug Corp, as the prime contractor, has previously received numerous federal contract awards from DLA to provide pharmaceuticals, medical supplies, and related...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $12,090.69, is for the supply of TREMFYA 100 MG/ML INJECTORML, a medication, with a period of performance through May 2, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This is a $8,493.51 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, for the provision of TREMFYA 100 MG/ML INJECTORML. The contract has an ultimate completion date of April 1, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary...
- The Defense Logistics Agency (DLA) awarded a $56,931.29 firm fixed price delivery order to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml injectable medication, with an ultimate completion date of April 22, 2025. This non-set-aside contract was competitively awarded and represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The place...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $8,315.82 firm-fixed-price delivery order contract (SPE2DX23F6MVB) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of TREMFYA 100 MG/ML SYRINGEML. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (SPE2DX15D1053) between Amerisourcebergen and DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to...
- This federal contract award, valued at $16,030.43, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the provision of TREMFYA 100 MG/ML SYRINGEML, a pharmaceutical product, with a completion date of December 27, 2024. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $62,826.70 firm fixed-price delivery order is for the supply of TREMFYA 100 MG/ML INJECTORML, a specialty medication. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This is a $26,182.78 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of TREMFYA 100 MG/ML SYRINGEML, a pharmaceutical product, with a period of performance through July 8, 2025. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FPU71Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $29,111.03 contract is for the supply of TREMFYA 100 MG/ML INJECTORML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA to provide a comprehensive range of pharmaceutical products and medical supplies to military treatment programs and facilities worldwide. The contract is not set aside for any specific business type.
Generated 6/27/24, 10:23 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.1k | 3/28/24 |